Sandoz Group Ltd ( ($CH:SDZ) ) has provided an announcement. Sandoz has launched TYRUKO® (natalizumab-sztn), the first and only FDA-approved ...

A 15-year-old beauty clinic employee has made shocking allegations about her former workplace, also the subject of a SafeWork NSW investigation, news.com.au can reveal.

A biology teacher has become the first patient in the UK to receive a “gamechanger” therapy to treat multiple sclerosis (MS). The CAR T-cell treatment, which experts believe could “transform” lives by ...

Emily Henders, 37, has become the first patient in the UK to receive a ‘gamechanger’ therapy to treat multiple sclerosis (Lucy North/PA) A biology teacher has become the first patient in the UK to ...

Emily Henders, 37, received her CAR T-cell therapy last week and hopes it will slow down or halt progression of her MS. Emily Henders, 37, has become the first patient in the UK to receive a ...

A biology teacher has been given a “gamechanger” therapy to treat multiple sclerosis (MS), becoming the first patient in the UK to receive the procedure. Experts believe the CAR T-cell treatment will ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

A biology teacher has become the first patient in the UK to receive a "gamechanger" therapy to treat multiple sclerosis (MS). The CAR T-cell treatment, which experts believe could "transform" lives by ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...